Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer
Watkins, Jack L., Thaker, Premal H., Nick, Alpa M., Ramondetta, Lois M., Kumar, Sanjeev, Urbauer, Diana L., Matsuo, Koji, Squires, Kathryn C., Coleman, Robert L., Lutgendorf, Susan K., Ramirez, Pedro T., Sood, Anil K.
Published in Cancer (01.10.2015)
Published in Cancer (01.10.2015)
Get full text
Journal Article
Evaluation of Pegylated Liposomal Doxorubicin Dose on the Adverse Drug Event Profile and Outcomes in Treatment of Recurrent Endometrial Cancer
Julius, Justin M., Tanyi, Janos L., Nogueras-Gonzalez, Graciela M., Watkins, Jack L., Coleman, Robert L., Wolf, Judith K., Smith, Judith A.
Published in International journal of gynecological cancer (01.02.2013)
Published in International journal of gynecological cancer (01.02.2013)
Get full text
Journal Article
Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary
Wallbillich, John J, Nick, Alpa M, Ramirez, Pedro T, Watkins, Jack L, Euscher, Elizabeth D, Schmeler, Kathleen M
Published in Gynecologic oncology case reports (2012)
Published in Gynecologic oncology case reports (2012)
Get full text
Journal Article
Clinical Impact of Selective and Non-selective Beta Blockers on Survival in Ovarian Cancer Patients
Watkins, Jack L., Thaker, Premal H., Nick, Alpa M., Ramondetta, Lois M., Kumar, Sanjeev, Urbauer, Diana L., Matsuo, Koji, Squires, Kathryn, Lutgendorf, Susan K., Ramirez, Pedro T., Sood, Anil K.
Published in Cancer (24.08.2015)
Published in Cancer (24.08.2015)
Get full text
Journal Article